Screener
NeoGenomics NEO CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by (used in) operating activities | 11,822 | (4,997) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Proceeds from maturities of marketable securities | — | 11,060 |
| Purchases of property and equipment | (13,219) | (10,823) |
| Business acquisition, net of cash acquired | — | (5,991) |
| Purchase of convertible note | (100) | — |
| Net cash used in investing activities | (13,319) | (5,754) |
| CASH FLOWS FROM FINANCING ACTIVITIES |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's capex?
- NeoGenomics (NEO) reported capex of $8.22M in Q2 2026.
- How has NeoGenomics's capex changed year-over-year?
- NeoGenomics's capex increased by 30.0% year-over-year, from $6.32M to $8.22M.
- What is the long-term trend for NeoGenomics's capex?
- Over 4 years (2021 to 2025), NeoGenomics's capex has grown at a -19.4% compound annual growth rate (CAGR), from $64.14M to $27.01M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about NeoGenomics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude